Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bexarotene + Photopheresis in CTCL
NCT00306969Phase 2Completed
- Sponsor
- Boston University
- Start
- Dec 2001
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of bexarotene in cutaneous T-cell lymphoma (CTCL), sponsored by Boston University. Started Dec 2001; status: completed.
02
Drugs
bexarotene
03
Conditions
cutaneous T-cell lymphoma (CTCL)
Beyond the preview
Go deeper on NCT00306969.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00306969.